{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:41Z","timestamp":1786991501472,"version":"build-2736575974"},"reference-count":153,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.jaut.2011.11.010","type":"journal-article","created":{"date-parts":[[2011,12,26]],"date-time":"2011-12-26T23:19:39Z","timestamp":1324941579000},"page":"J197-J208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome"],"prefix":"10.1016","volume":"38","author":[{"given":"Laura","family":"Andreoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Fredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Nalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Reggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lojacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tincani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaut.2011.11.010_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.jaut.2011.11.010_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2362.2010.02443.x","article-title":"Lupus and pregnancy: integrating clues from the bench and bedside","volume":"41","author":"Ruiz-Irastorza","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.jaut.2011.11.010_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/rheumatology\/keq350","article-title":"Pregnancy and reproduction in autoimmune rheumatic diseases","volume":"50","author":"Ostensen","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2011.11.010_bib4","doi-asserted-by":"crossref","first-page":"iii9","DOI":"10.1093\/rheumatology\/ken151","article-title":"Challenges of lupus pregnancies","volume":"47","author":"Doria","year":"2008","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jaut.2011.11.010_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ndt\/gfn348","article-title":"Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome","volume":"24","author":"Imbasciati","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.jaut.2011.11.010_bib6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.20864","article-title":"The impact of increased lupus activity on obstetrical outcomes","volume":"52","author":"Clowse","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.010_bib7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3899\/jrheum.100746","article-title":"The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus","volume":"38","author":"Clowse","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.jaut.2011.11.010_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00404-003-0574-x","article-title":"Pregnancy outcome in lupus nephropathy","volume":"271","author":"Rahman","year":"2005","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.jaut.2011.11.010_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/096120339100100104","article-title":"The outcome of pregnancy in women with lupus nephritis","volume":"1","author":"Oviasu","year":"1991","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.jaut.2011.11.010_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/ajkd.2002.35678","article-title":"Pregnancy in lupus nephritis","volume":"40","author":"Moroni","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.jaut.2011.11.010_bib11","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3899\/jrheum.100997","article-title":"Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis","volume":"38","author":"Bramham","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.jaut.2011.11.010_bib12","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A\u00a0systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.jaut.2011.11.010_bib13","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1002\/art.20638","article-title":"The effect of pregnancy on lupus nephritis","volume":"50","author":"Tandon","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.010_bib14","series-title":"Heart disease in pregnancy","first-page":"136","article-title":"Heart disease, pregnancy and systemic autoimmune diseases","author":"Ruiz-Irastorza","year":"2007"},{"key":"10.1016\/j.jaut.2011.11.010_bib15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00000542-200506000-00012","article-title":"Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases","volume":"102","author":"Bonnin","year":"2005","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.jaut.2011.11.010_bib16","doi-asserted-by":"crossref","first-page":"127.e1","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A\u00a0national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaut.2011.11.010_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regolatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.jaut.2011.11.010_bib18","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/acr.20466","article-title":"Decreased live births in women with systemic lupus erythematosus","volume":"63","author":"Vinet","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2 Pt 1","key":"10.1016\/j.jaut.2011.11.010_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.AOG.0000194205.95870.86","article-title":"Early risk factors for pregnancy loss in lupus","volume":"107","author":"Clowse","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaut.2011.11.010_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1874312900802010089","article-title":"Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: results from a case control study and literature review","volume":"2","author":"Yan Yuen","year":"2008","journal-title":"Open Rheumatol J"},{"issue":"10","key":"10.1016\/j.jaut.2011.11.010_bib21","first-page":"2127","article-title":"Preterm deliveries in women with systemic lupus erythematosus","volume":"30","author":"Clark","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2011.11.010_bib22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/0961203310394894","article-title":"Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery","volume":"20","author":"Stagnaro-Green","year":"2011","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jaut.2011.11.010_bib23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0029-7844(95)00186-U","article-title":"Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic","volume":"86","author":"Johnson","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jaut.2011.11.010_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0002-9378(98)70277-7","article-title":"Placental pathology in systemic lupus erythematosus: a prospective study","volume":"179","author":"Magid","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaut.2011.11.010_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/rheumatology\/kei159","article-title":"The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and\/or the antiphospholipid syndrome","volume":"45","author":"Le Thi Houng","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2011.11.010_bib26","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/rheumatology\/kel212","article-title":"Uterine artery Doppler in predicting pregnancy outcome in women with connective tissue disorders","volume":"45","author":"Castellino","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2011.11.010_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-3083.2010.02443.x","article-title":"Non-cardiac manifestations of neonatal lupus erythematosus","volume":"72","author":"Silverman","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2011.11.010_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1525-1470.2003.03014.x","article-title":"Central nervous system involvement in neonatal lupus erythematosus","volume":"20","author":"Prendville","year":"2003","journal-title":"Ped Dermatol"},{"key":"10.1016\/j.jaut.2011.11.010_bib29","doi-asserted-by":"crossref","first-page":"F355","DOI":"10.1136\/adc.2010.195099","article-title":"Cerebral ultrasound abnormalities in infants born to mothers with autoimmune disease","volume":"96","author":"Motta","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal"},{"key":"10.1016\/j.jaut.2011.11.010_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-3083.2010.02437.x","article-title":"Spectrum of cardiac involvement in neonatal lupus","volume":"72","author":"Hornberger","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2011.11.010_bib31","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3899\/jrheum.100317","article-title":"A\u00a0new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal anti-SSA\/Ro and anti-SSB\/La antibodies","volume":"38","author":"Guettrot-Imbert","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2011.11.010_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12016-009-8190-6","article-title":"Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies","volume":"40","author":"Brucato","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaut.2011.11.010_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2010.149021.14","article-title":"Development of heart block in children of SSA\/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern","author":"Ambrosi","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2011.11.010_bib34","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jaut.2011.11.010_bib35","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/art.27333","article-title":"Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block","volume":"62","author":"Izmirly","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.010_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-3083.2010.02442.x","article-title":"Autoantibodies associated with congenital heart block","volume":"72","author":"Salomonsson","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2011.11.010_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2249.2008.03732.x","article-title":"Antibodies to amino acid 200\u2013239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block","volume":"154","author":"Strandberg","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2011.11.010_bib38","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.4049\/jimmunol.1001396","article-title":"Maternal MHC regulates generation of pathogenic autoantibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block","volume":"185","author":"Strandberg","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2011.11.010_bib39","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1002\/art.27658","article-title":"Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus","volume":"62","author":"Clancy","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.010_bib40","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/art.27575","article-title":"Passively acquired anti-SSA\/Ro antibodies are required for congenital heart block following ovodonation but maternal genes are not","volume":"62","author":"Brucato","year":"2010","journal-title":"Arhtritis Rheum"},{"issue":"10","key":"10.1016\/j.jaut.2011.11.010_bib41","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro\u2013SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2011.11.010_bib42","doi-asserted-by":"crossref","first-page":"i35","DOI":"10.1093\/rheumatology\/ken153","article-title":"Prevention of congenital heart block in children of SSA-positive mothers","volume":"47","author":"Brucato","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2011.11.010_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-3083.2010.02434.x","article-title":"Diagnosing foetal atrioventricular heart blocks","volume":"72","author":"Sonesson","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2011.11.010_bib44","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/BOR.0b013e32832ed817","article-title":"Prevention of complete heart block in children of mothers with anti-SSA\/Ro and anti-SSB\/La autoantibodies: detection and treatment of first-degree atrioventricular block","volume":"21","author":"Mevorach","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2011.11.010_bib45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR interval and dexamethasone evaluation (PRIDE)","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2011.11.010_bib46","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jacc.2010.12.014","article-title":"Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro\/SSA and anti-La\/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses","volume":"57","author":"Jaeggi","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaut.2011.11.010_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-3083.2010.02440.x","article-title":"The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro\/SSA antibodies: a review","volume":"72","author":"Hutter","year":"2010","journal-title":"Scand J Immunol"},{"issue":"8","key":"10.1016\/j.jaut.2011.11.010_bib48","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR interval and dexamethasone evaluation (PRIDE) study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jaut.2011.11.010_bib49","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ard.62.10.1010","article-title":"Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block","volume":"62","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2011.11.010_bib50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.11498","article-title":"Intravenous immunoglobulin and placental transport of anti-Ro\/La antibodies: comment on the letter by Kaaja and Julkunen","volume":"50","author":"Tran","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jaut.2011.11.010_bib51","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.jaut.2011.11.010_bib52","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.010_bib53","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/art.30464","article-title":"Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block","volume":"63","author":"Routsias","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jaut.2011.11.010_bib54","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/00016340701343024","article-title":"Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and\/or Sj\u00f6gren\u2019s syndrome","volume":"86","author":"Makino","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jaut.2011.11.010_bib55","doi-asserted-by":"crossref","first-page":"A299","DOI":"10.1016\/j.autrev.2009.11.013","article-title":"The geoepidemiology of the antiphospholipid syndrome","volume":"9","author":"Biggioggero","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2011.11.010_bib56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0028-1082270","article-title":"Lupus and the antiphospholipid sindrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment","volume":"34","author":"Tincani","year":"2008","journal-title":"Semin Thromb Hemost"},{"issue":"20","key":"10.1016\/j.jaut.2011.11.010_bib57","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/0961203310395055","article-title":"\u2018Criteria\u2019 aPL tests: report of a task force and preconference workshop at the 13th international Congress on antiphospholipid antibodies, Galveston, Texas, April 2010","author":"Pierangeli","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.010_bib58","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0028-1082267","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanism","volume":"34","author":"Pierangeli","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jaut.2011.11.010_bib59","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0028-2243(91)90021-C","article-title":"Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies","volume":"41","author":"Out","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jaut.2011.11.010_bib60","first-page":"1684","article-title":"Beta2glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome","author":"La Rosa","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2011.11.010_bib61","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"15","key":"10.1016\/j.jaut.2011.11.010_bib62","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1182\/blood-2011-01-333617","article-title":"In\u00a0vivo distribution of beta2glycoprotein I under various pathophysiological conditions","volume":"118","author":"Agostinis","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2011.11.010_bib63","unstructured":"Personal communication of Prof. Pier Luigi Meroni."},{"key":"10.1016\/j.jaut.2011.11.010_bib64","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0961203310361485","article-title":"The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis","volume":"19","author":"Rand","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.010_bib65","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ard.2004.021444","article-title":"Pathogenic role of anti-beta2glycoprotein I antibodies in antiphospholipid-associated fetal loss: characterisation of beta2glycoprotein I binding to trophoblast cells and functional effects of anti-beta2glycoprotein I antibodies in\u00a0vitro","volume":"64","author":"Di Simone","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2011.11.010_bib66","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1191\/0961203306lu2315oa","article-title":"A\u00a0peptide that mimics the Vth region of beta2glycoprotein I reverses antiphospholipid mediated thrombosis in mice","volume":"15","author":"Ostertag","year":"2006","journal-title":"Lupus"},{"issue":"S404","key":"10.1016\/j.jaut.2011.11.010_bib67","article-title":"Pregnant na\u00efve mice are protected from aPL-induced fetal loss by the injection of a synthetic peptide (TIFI) mimicking the beta2GPI PL-binding site","volume":"58","author":"Martinez de la Torre","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jaut.2011.11.010_bib68","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1365-2362.2001.00866.x","article-title":"Induction and treatment of the antiphospholipid syndrome \u2013 lessons from animal models","volume":"31","author":"Shoenfeld","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaut.2011.11.010_bib69","first-page":"3453","article-title":"Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome","volume":"118","author":"Redecha","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2011.11.010_bib70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2011.11.010_bib71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molimm.2004.07.043","article-title":"A\u00a0novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice","volume":"42","author":"Thurman","year":"2005","journal-title":"Mol Immunol"},{"issue":"11","key":"10.1016\/j.jaut.2011.11.010_bib72","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nature Med"},{"key":"10.1016\/j.jaut.2011.11.010_bib73","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","volume":"2","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaut.2011.11.010_bib74","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2007.02.013","article-title":"Complement activation in antiphospholipid syndrome: a clue for an inflammatory process?","volume":"28","author":"Cavazzana","year":"2007","journal-title":"J\u00a0Autoimmun"},{"issue":"2","key":"10.1016\/j.jaut.2011.11.010_bib75","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2006.10.879","article-title":"Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies","volume":"196","author":"Shamonki","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"2010","key":"10.1016\/j.jaut.2011.11.010_bib76","article-title":"Complement involvement in antiphospholipid antibody-mediated placental damage: prospective study in APS pregnant women","volume":"68","author":"Gerosa","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaut.2011.11.010_bib77","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11926-007-0035-9","article-title":"Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?","volume":"9","author":"Clark","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jaut.2011.11.010_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2011.05.007","article-title":"HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies","author":"Appenzeller","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.010_bib79","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-009-0010-8","article-title":"Neonatal effects of maternal antiphospholipid syndrome","volume":"11","author":"Tincani","year":"2009","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.jaut.2011.11.010_bib80","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0961203310395054","article-title":"Obstetric task force report of the obstetric APS task force: 13th international congress on antiphospholipid antibodies, 13th April 2010","volume":"20","author":"Branch","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.010_bib81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/03009742.1998.11720701","article-title":"Interleukin-3 and pregnancy loss in antiphospholipid syndrome","volume":"107","author":"Shoenfeld","year":"1998","journal-title":"Scand J Rheumatol Suppl"},{"issue":"Suppl. 3","key":"10.1016\/j.jaut.2011.11.010_bib82","first-page":"iii23","article-title":"Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers","volume":"47","author":"Erkan","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.jaut.2011.11.010_bib83","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.jaut.2011.11.010_bib84","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid syndrome and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaut.2011.11.010_bib85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","article-title":"Anti-inflammatory and immunosuppressive drugs and reproduction","volume":"8","author":"\u00d8stensen","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"Suppl. 3","key":"10.1016\/j.jaut.2011.11.010_bib86","first-page":"iii28","article-title":"Update on safety of biological agents and some immunosuppressive anti-rheumatic drugs","volume":"47","author":"\u00d8stensen","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2011.11.010_bib87","first-page":"368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study","volume":"327","author":"Li","year":"2003","journal-title":"Br\u00a0Med J"},{"key":"10.1016\/j.jaut.2011.11.010_bib88","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","article-title":"Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study","volume":"322","author":"Nielsen","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jaut.2011.11.010_bib89","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1503\/cmaj.110454","article-title":"Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion","volume":"183","author":"Nakhai-Pour","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.jaut.2011.11.010_bib90","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.ede.0000221693.72971.b3","article-title":"Aspirin use and miscarriage risk","volume":"17","author":"Keim","year":"2006","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.jaut.2011.11.010_bib91","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/bdrb.10002","article-title":"Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis","volume":"68","author":"Kozer","year":"2003","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.jaut.2011.11.010_bib92","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archotol.1964.00750040419009","article-title":"The ototoxicity of chloroquine phosphate","volume":"80","author":"Hart","year":"1964","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.jaut.2011.11.010_bib93","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.010_bib94","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1471-0528.1980.tb04434.x","article-title":"Successful pregnancies in women treated by dialysis and kidney transplantation","volume":"87","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jaut.2011.11.010_bib95","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/tera.10043","article-title":"Teratogen update: azathioprine and 6-mercaptopurine","volume":"65","author":"Polifka","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.jaut.2011.11.010_bib96","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/bdra.20399","article-title":"Pregnancy outcome of women exposed to azathioprine during pregnancy","volume":"79","author":"Goldstein","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.jaut.2011.11.010_bib97","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/bdra.20583","article-title":"Early pregnancy azathioprine use and pregnancy outcomes","volume":"85","author":"Clearly","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"3","key":"10.1016\/j.jaut.2011.11.010_bib98","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.reprotox.2011.08.008","article-title":"The transfer of 6-mercaptopurine in the dually perfused human placenta","volume":"32","author":"Hutson","year":"2011","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jaut.2011.11.010_bib99","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1002\/jps.22631","article-title":"6-Mercaptopurine transport by equilibrative nucleoside transporters in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBTs","volume":"100","author":"Lee","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.jaut.2011.11.010_bib100","first-page":"S1","article-title":"Rituximab (MabThera) therapy and safety management. Clinical tool guide","volume":"75","author":"Pham","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.jaut.2011.11.010_bib101","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2011.11.010_bib102","series-title":"Package insert","year":"2011"},{"issue":"6\u00a0Suppl","key":"10.1016\/j.jaut.2011.11.010_bib103","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"American College of Chest Physicians venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jaut.2011.11.010_bib104","doi-asserted-by":"crossref","first-page":"457.e1","DOI":"10.1016\/j.ajog.2007.04.022","article-title":"Pregnancy and Thrombosis Working Group. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes","volume":"197","author":"Duhl","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1027","key":"10.1016\/j.jaut.2011.11.010_bib105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/pgmj.2010.103606","article-title":"Prescribing in pregnancy and during breast feeding: using principles in clinical practice","volume":"87","author":"Henderson","year":"2011","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaut.2011.11.010_bib106","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1038\/ncprheum0532","article-title":"Therapy insight: the use of antirheumatic drugs during nursing","volume":"3","author":"Ostensen","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jaut.2011.11.010_bib107","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJM200007133430208","article-title":"Drug therapy for breast-feeding woman","volume":"343","author":"Ito","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2011.11.010_bib108","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1191\/0961203303lu2004oa","article-title":"Disease specific problems related to drug therapy in pregnancy","volume":"13","author":"Ostensen","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.010_bib109","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1191\/0961203305lu2169oa","article-title":"Cyclophosphamide for lupus during pregnancy","volume":"14","author":"Clowse","year":"2005","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jaut.2011.11.010_bib110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/acr.20402","article-title":"Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?","volume":"63","author":"Yazdany","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaut.2011.11.010_bib111","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrrheum.2011.54","article-title":"Connective tissue diseases: contraception counselling in SLE\u2014an\u00a0often forgotten duty?","volume":"7","author":"Ostensen","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaut.2011.11.010_bib112","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/AOG.0b013e3181ae9c64","article-title":"Safety of contraceptive method use among women with systemic lupus erythematosus. A systematic review","volume":"114","author":"Culwell","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jaut.2011.11.010_bib113","doi-asserted-by":"crossref","first-page":"193.e1","DOI":"10.1016\/j.ajog.2007.04.028","article-title":"Intrauterine device use in a high-risk population: experience from an urban university clinic","volume":"197","author":"Campbell","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaut.2011.11.010_bib114","doi-asserted-by":"crossref","first-page":"144.e1","DOI":"10.1016\/j.ajog.2007.03.031","article-title":"A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus","volume":"197","author":"Stringer","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaut.2011.11.010_bib115","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1093\/rheumatology\/ken150","article-title":"Oestrogens in rheumatic diseases: friend or foe?","volume":"47","author":"Cutolo","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"24","key":"10.1016\/j.jaut.2011.11.010_bib116","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A\u00a0trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"S\u00e1nchez-Guerrero","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.jaut.2011.11.010_bib117","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jaut.2011.11.010_bib118","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/berh.2002.0225","article-title":"Buyon JP. Reproductive health in SLE","volume":"16","author":"Askanase","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jaut.2011.11.010_bib119","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2010.08.012","article-title":"Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients","volume":"83","author":"Chabbert-Buffet","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jaut.2011.11.010_bib120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2007.10.005","article-title":"Bone density recovery after depot medroxyprogesterone acetate injectable contraception use","volume":"77","author":"Kaunitz","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.jaut.2011.11.010_bib121","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2010.07.027","article-title":"The effect of depot medroxyprogesterone acetate DMPA on bone mineral density BMD and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age","volume":"83","author":"Gai","year":"2011","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.jaut.2011.11.010_bib122","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/rheumatology\/38.6.559","article-title":"Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study","volume":"38","author":"Hardy","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2011.11.010_bib123","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/rheumatology\/ker105","article-title":"Causes and management of infertility in systemic lupus erythematosus","volume":"50","author":"Hickman","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2011.11.010_bib124","first-page":"315","article-title":"Lupus nephritis and pregnancy","volume":"83","author":"Packham","year":"1992","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1016\/j.jaut.2011.11.010_bib125","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/acr.20323","article-title":"Maintanance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs","volume":"62","author":"Silva","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaut.2011.11.010_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2011.05.008","article-title":"Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases","author":"Blumenfeld","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.010_bib127","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/acr.20510","article-title":"Luteneized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropaties","volume":"63","author":"Micu","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jaut.2011.11.010_bib128","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y","article-title":"Ovulation induction and in\u00a0vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome","volume":"43","author":"Guballa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.010_bib129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/sarh.2002.37212","article-title":"Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles","volume":"32","author":"Le Thi Huong","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.010_bib130","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.fertnstert.2009.06.033","article-title":"Ovarian stimulation for ovulation induction and in\u00a0vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid sindrome","volume":"92","author":"Bellver","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaut.2011.11.010_bib131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/jaut.2000.0416","article-title":"Management of patients with antiphospholipid antibodies undergoing in\u00a0vitro fertilization","volume":"15","author":"Udoff","year":"2000","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2011.11.010_bib132","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0961203306071005","article-title":"Impact of in utero environment on the offspring of lupus patients","volume":"15","author":"Tincani","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.010_bib133","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/0961203306071003","article-title":"Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases","volume":"15","author":"Parke","year":"2006","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.jaut.2011.11.010_bib134","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.earlhumdev.2005.09.004","article-title":"Management of preterm infants with intrauterine growth restriction","volume":"81","author":"Fang","year":"2005","journal-title":"Early Hum Dev."},{"key":"10.1016\/j.jaut.2011.11.010_bib135","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1542\/peds.2007-1659","article-title":"Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52\/SSA autoantibodies","volume":"121","author":"Skog","year":"2008","journal-title":"Pediatrics"},{"issue":"18","key":"10.1016\/j.jaut.2011.11.010_bib136","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and fetal factors associated with mortality and morbidity in a multi-racial\/ethnic registry of anti-SSA\/Ro-associated cardiac neonatal lupus","volume":"124","author":"Izmirly","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jaut.2011.11.010_bib137","first-page":"767","article-title":"Neuropsychiatric aid in children born to patients with rheumatic diseases","volume":"28","author":"Bomba","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaut.2011.11.010_bib138","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/0961203308089326","article-title":"Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus","volume":"17","author":"Urowitz","year":"2008","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.jaut.2011.11.010_bib139","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1191\/0961203304lu2018oa","article-title":"Neuropsychological development of children born to patients with systemic lupus erythematosus","volume":"13","author":"Neri","year":"2004","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.jaut.2011.11.010_bib140","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1073\/pnas.81.7.1996","article-title":"The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs","volume":"81","author":"Wolin","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jaut.2011.11.010_bib141","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archpedi.157.4.397","article-title":"Effects of mothers\u2019 autoimmune disease during pregnancy on learning disabilities and hand preference in their children","volume":"157","author":"Ross","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"10.1016\/j.jaut.2011.11.010_bib142","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1469-8749.1985.tb04582.x","article-title":"Anti-Ro antibody in mothers of dyslexic children","volume":"27","author":"Behan","year":"1985","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jaut.2011.11.010_bib143","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1136\/ard.2005.049866","article-title":"Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero","volume":"65","author":"Brucato","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2011.11.010_bib144","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0961203309354542","article-title":"Frequency of neuro-psychiatric dysfunction in anti-SSA\/SSB exposed children with and without neonatal lupus","volume":"19","author":"Askanase","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.010_bib145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/art.23311","article-title":"Neuropsychological development of children born to patients with antiphospholipid syndrome","volume":"59","author":"Nacinovich","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.010_bib146","first-page":"25","article-title":"European registry of infants born to mothers with antiphospholipid syndrome: preliminary results","volume":"62","author":"Motta","year":"2010","journal-title":"Minerva Pediatr"},{"issue":"Suppl. 3","key":"10.1016\/j.jaut.2011.11.010_bib147","first-page":"iii32","article-title":"Follow-up of children exposed antenatally to immunosuppressive drugs","volume":"47","author":"Motta","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2011.11.010_bib148","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0961203306075738","article-title":"Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders","volume":"16","author":"Cimaz","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.010_bib149","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.toxlet.2003.12.030","article-title":"Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy","volume":"149","author":"Cimaz","year":"2004","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jaut.2011.11.010_bib150","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-2007-986679","article-title":"Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents","volume":"24","author":"Motta","year":"2007","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jaut.2011.11.010_bib151","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0961203306071869","article-title":"Characterization of T-cell population with prolonged fetal exposure to dexamethasone for anti-Ro\/SS-A antibodies associated congenital heart block","volume":"15","author":"Air\u00f2","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.010_bib152","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-2006-939533","article-title":"Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study","volume":"23","author":"Motta","year":"2006","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.jaut.2011.11.010_bib153","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2010.137281","article-title":"Anti-\u03b2\u2082-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4\/5: might it be the reason for their \u2018innocent\u2019 profile?","volume":"70","author":"Andreoli","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841111001235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841111001235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:07:33Z","timestamp":1760256453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841111001235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":153,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0896841111001235"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2011.11.010","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2011.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}